1. 1MCD, Centre de Biologie Intégrative, Université de Toulouse, Centre National de la Recherche Scientifique (CNRS), UT3, Toulouse, France;
2. 2University of Paris Cité, Paris, France;
3. 3Hematim EA4666, Amiens, France;
4. 4Laboratory of Excellence for Red Cells, LABEX GR-Ex, Paris, France;
5. 5Service d’Hématologie Biologique, Assistance Publique–Hôpitaux de Paris (AP-HP), Hôpital Robert Debré, Paris, France;
6. 6Amsterdam UMC, University of Amsterdam, Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology, Endocrinology, and Metabolism, Amsterdam, The Netherlands;
7. 7Pediatric Hematology Unit, Department of Pediatrics, Medical Faculty, and
8. 8Research Center on Fanconi Anemia and Other Inherited Bone Marrow Failure Syndromes, Hacettepe University, Ankara, Turkey;
9. 9RNA Molecular Biology, Fonds de la Recherche Scientifique (F.R.S./FNRS), Université libre de Bruxelles (ULB), Gosselies, Belgium;
10. 10Department of Pediatric Hematology and
11. 11Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands;
12. 12Princess Máxima Center for Pediatric Oncology, Department of Pathology, Utrecht, The Netherlands;
13. 13Laboratory for Disease Mechanisms in Cancer, Department of Oncology, Katholieke Universiteit Leuven (KU Leuven) and Leuven Cancer Institute (LKI), Leuven, Belgium;
14. 14Department of Pediatric Hemato-Oncology, University Hospitals Leuven, Leuven, Belgium;
15. 15UMR S1134, INSERM, Paris, France;
16. 16UMR 1297-I2MC, INSERM, Université de Toulouse, Toulouse, France;
17. 17Pediatric Genetics Unit, Department of Pediatrics, Medical Faculty, Hacettepe University, Ankara, Turkey;
18. 18Immuno-Hematology Department, Hôpital Robert-Debré, Assistance Publique-Hôpitaux de Paris, Paris, France;
19. 19EA-3518, Université Paris Cité, Paris, France;
20. 20Pediatric Hematology Unit, Department of Pediatrics, Medical Faculty, Yildirim Beyazit University, Ankara, Turkey; and
21. 21Department of Medical Genetics, Medical Faculty, Hacettepe University, Ankara, Turkey